Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - adefovirum dipivoxilum - comprimés - adefovirum dipivoxilum 10 mg, excipiens pro compresso. - l'hépatite b chronique - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - tenofovirum alafenamidum - comprimés pelliculés - tenofovirum alafenamidum 25 mg pour tenofoviri alafenamidi hemifumaras, lactosum monohydricum 94.96 mg, cellulosum microcristallinum, carmellosum natricum seulement tenus ensemble, magnésium stearas, Überzug: poly(alcool vinylicus), macrogolum, talc, e 171, e 172 (jaune), pour compresso haze corresp. sodium 1.331 mg. - l'hépatite b chronique - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - bictegravirum, emtricitabinum, tenofovirum alafenamidum - comprimés pelliculés - bictegravirum 50 mg à bictegravirum natricum, emtricitabinum 200 mg, tenofovirum alafenamidum 25 mg pour tenofoviri alafenamidi hemifumaras, cellulosum microcristallinum, carmellosum natricum seulement tenus ensemble, magnésium stearas, Überzug: poly(alcool vinylicus), macrogolum, talc, e 171, e 172 (rouge) e 172 (noir), pour compresso haze corresp. sodium 7.267 mg. - l'infection à vih - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - axicabtagenum ciloleucelum zelldispersion de 0.4 – 2 x 10e8 cellules/simple-poche (68 ml) - yescarta - beutel: axicabtagenum ciloleucelum zelldispersion von 0.4 – 2 x 10e8 zellen/einzel-infusionsbeutel (68 ml), natrii chloridum, albuminum de l'homme, cryostor cs10 34 ml corresp. dimethylis sulfoxidum 5 % v/v, à la préparation. - yescarta ist eine gegen cd19 gerichtete, genetisch modifizierte autologe t-zell-immuntherapie und wird angewendet bei erwachsenen patienten zur behandlung von; • diffusem grosszelligem b-zell-lymphom (dlbcl) oder high-grade-b-zell-lymphom (hgbl), das auf die erstlinien-chemoimmuntherapie refraktär ist oder innerhalb von 12 monaten nach der erstlinien-chemoimmuntherapie rezidiviert; • rezidiviertem oder refraktärem (r/r) dlbcl oder primärem mediastinalem grosszelligem b-zell-lymphom (pmbcl) nach zwei oder mehr systemischen therapielinien. ; • yescarta wird angewendet zur behandlung von erwachsenen patienten mit rezidiviertem oder refraktärem follikulärem lymphom (fl) nach drei oder mehr systemischen therapielinien. - greffe: gentherapieprodukt

Union européenne - français - EMA (European Medicines Agency)

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Union européenne - français - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - agents antinéoplasiques - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

Union européenne - français - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - infections au vih - antiviraux à usage systémique - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 et 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 et 5.

Canada - français - Health Canada

gilead sciences canada inc - emtricitabine; rilpivirine (chlorhydrate de rilpivirine); ténofovir alafénamide (hémifumarate de ténofovir alafénamide) - comprimé - 200mg; 25mg; 25mg - emtricitabine 200mg; rilpivirine (chlorhydrate de rilpivirine) 25mg; ténofovir alafénamide (hémifumarate de ténofovir alafénamide) 25mg - nonnucleoside reverse transcriptase inhibitors

Canada - français - Health Canada

gilead sciences, llc - Éfavirenz; emtricitabine; fumarate de ténofovir disoproxil - comprimé - 600mg; 200mg; 300mg - Éfavirenz 600mg; emtricitabine 200mg; fumarate de ténofovir disoproxil 300mg - nonnucleoside reverse transcriptase inhibitors

Canada - français - Health Canada

gilead sciences canada inc - fumarate de ténofovir disoproxil - comprimé - 300mg - fumarate de ténofovir disoproxil 300mg - nucleoside and nucleotide reverse transcriptase inhibitors